These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hematopoietic stem cell transplantation for pediatric patients with non-anaplastic peripheral T-cell lymphoma. An EBMT pediatric diseases working party study. Moser O; Ngoya M; Galimard JE; Dalissier A; Dalle JH; Kalwak K; Wössmann W; Burkhardt B; Bierings M; Gonzalez-Vicent M; López Corral L; Mellgren K; Attarbaschi A; Bourhis JH; Carlson K; Corbacioglu S; Drabko K; Sundin M; Toporski J; Cario G; Kontny U Bone Marrow Transplant; 2024 May; 59(5):604-614. PubMed ID: 38331982 [TBL] [Abstract][Full Text] [Related]
23. [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas]. Wójcik B; Kowalczyk JR; Chybicka A; Wachowiak J; Drabko K; Zaucha-Prazmo A; Choma M; Gorczyńska E; Toporski J; Turkiewicz D; Kałwak K; Pieczonka A; Boruczkowski D Przegl Lek; 2004; 61 Suppl 2():53-6. PubMed ID: 15686047 [TBL] [Abstract][Full Text] [Related]
24. Relapse of lymphoma after allogeneic hematopoietic cell transplantation: management strategies and outcome. Wudhikarn K; Brunstein CG; Bachanova V; Burns LJ; Cao Q; Weisdorf DJ Biol Blood Marrow Transplant; 2011 Oct; 17(10):1497-504. PubMed ID: 21338707 [TBL] [Abstract][Full Text] [Related]
25. Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma. Czajczynska A; Günther A; Repp R; Humpe A; Schub N; Raff T; Nickelsen M; Schrauder A; Schrappe M; Kneba M; Gramatzki M Biol Blood Marrow Transplant; 2013 Nov; 19(11):1632-7. PubMed ID: 23850653 [TBL] [Abstract][Full Text] [Related]
26. Myeloablative intravenous pharmacokinetically targeted busulfan plus fludarabine as conditioning for allogeneic hematopoietic cell transplantation in patients with non-Hodgkin lymphoma. Ayala E; Figueroa J; Perkins J; Kim J; Yue B; Riches M; Nishihori T; Locke F; Anasetti C; Kharfan-Dabaja MA Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):335-40. PubMed ID: 25659459 [TBL] [Abstract][Full Text] [Related]
27. Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: importance of histology for outcome. Armand P; Kim HT; Ho VT; Cutler CS; Koreth J; Antin JH; LaCasce AS; Jacobsen ED; Fisher DC; Brown JR; Canellos GP; Freedman AS; Soiffer RJ; Alyea EP Biol Blood Marrow Transplant; 2008 Apr; 14(4):418-25. PubMed ID: 18342784 [TBL] [Abstract][Full Text] [Related]
28. Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Freytes CO; Zhang MJ; Carreras J; Burns LJ; Gale RP; Isola L; Perales MA; Seftel M; Vose JM; Miller AM; Gibson J; Gross TG; Rowlings PA; Inwards DJ; Pavlovsky S; Martino R; Marks DI; Hale GA; Smith SM; Schouten HC; Slavin S; Klumpp TR; Lazarus HM; van Besien K; Hari PN Biol Blood Marrow Transplant; 2012 Aug; 18(8):1255-64. PubMed ID: 22198543 [TBL] [Abstract][Full Text] [Related]
29. Hematopoietic stem cell transplantation in the new millennium: report from City of Hope National Medical Center. Molina A; Popplewell L; Kashyap A; Nademanee A Clin Transpl; 2000; ():317-42. PubMed ID: 11512326 [TBL] [Abstract][Full Text] [Related]
30. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma. Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059 [TBL] [Abstract][Full Text] [Related]
31. Allogeneic haematopoietic stem cell transplantation in relapsed or refractory anaplastic large cell lymphoma of children and adolescents--a Berlin-Frankfurt-Münster group report. Woessmann W; Peters C; Lenhard M; Burkhardt B; Sykora KW; Dilloo D; Kremens B; Lang P; Führer M; Kühne T; Parwaresch R; Ebell W; Reiter A Br J Haematol; 2006 Apr; 133(2):176-82. PubMed ID: 16611309 [TBL] [Abstract][Full Text] [Related]
32. Risk factors predicting the survival of pediatric patients with relapsed/refractory non-Hodgkin lymphoma who underwent hematopoietic stem cell transplantation: a retrospective study from the Turkish pediatric bone marrow transplantation registry. Hazar V; Kesik V; Karasu GT; Öztürk G; Küpesiz A; Kılıç SÇ; Ataş E; Uygun V; Eker N; Erbey F; Bengoa ŞY; Emir S; Anak S; Öniz H; Daloğlu H; Aksoylar S; Koçak Ü; Karakükçü M; Elli M; Kurucu N; Yeşilipek A Leuk Lymphoma; 2018 Jan; 59(1):85-96. PubMed ID: 28571522 [TBL] [Abstract][Full Text] [Related]
33. Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy. Calderón-Cabrera C; Márquez-Malaver FJ; de la Cruz-Vicente F; Falantes F; Carrillo E; Parody R; Montero I; González Campos J; Martino ML; Carmona M; Pérez-Simón JA; Espigado I Transplant Proc; 2013; 45(10):3665-7. PubMed ID: 24314990 [TBL] [Abstract][Full Text] [Related]
34. Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant. Ghosh N; Ahmed S; Ahn KW; Khanal M; Litovich C; Aljurf M; Bacher VU; Bredeson C; Epperla N; Farhadfar N; Freytes CO; Ganguly S; Haverkos B; Inwards D; Kamble RT; Lazarus HM; Lekakis L; Murthy HS; Nishihori T; Ramakrishnan P; Rizzieri DA; Yared JA; Kharfan-Dabaja MA; Sureda A; Hamadani M JAMA Oncol; 2020 Jul; 6(7):1011-1018. PubMed ID: 32496525 [TBL] [Abstract][Full Text] [Related]
35. Allogeneic Stem Cell Transplantation from HLA-Mismatched Donors for Pediatric Patients with Acute Lymphoblastic Leukemia Treated According to the 2003 BFM and 2007 International BFM Studies: Impact of Disease Risk on Outcomes. Dalle JH; Balduzzi A; Bader P; Lankester A; Yaniv I; Wachowiak J; Pieczonka A; Bierings M; Yesilipek A; Sedlaçek P; Ifversen M; Sufliarska S; Toporski J; Glogova E; Poetschger U; Peters C Biol Blood Marrow Transplant; 2018 Sep; 24(9):1848-1855. PubMed ID: 29772352 [TBL] [Abstract][Full Text] [Related]
36. Assessment of the hematopoietic cell transplantation comorbidity index in non-Hodgkin lymphoma patients receiving reduced-intensity allogeneic hematopoietic stem cell transplantation. Pollack SM; Steinberg SM; Odom J; Dean RM; Fowler DH; Bishop MR Biol Blood Marrow Transplant; 2009 Feb; 15(2):223-30. PubMed ID: 19167682 [TBL] [Abstract][Full Text] [Related]
37. Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma. Maloney DG Leuk Lymphoma; 2003; 44 Suppl 3():S99-105. PubMed ID: 15202532 [TBL] [Abstract][Full Text] [Related]
38. Effects of second transplantation with T-cell-replete haploidentical graft using low-dose anti-thymocyte globulin on long-term overall survival in pediatric patients with relapse of leukemia after first allogeneic transplantation. Kobayashi S; Sano H; Mochizuki K; Ohara Y; Takahashi N; Kudo S; Ikeda K; Ohto H; Kikuta A Int J Hematol; 2022 Mar; 115(3):414-423. PubMed ID: 34822127 [TBL] [Abstract][Full Text] [Related]
39. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation. Truelove E; Fox C; Robinson S; Pearce R; Perry J; Kirkland K; McQuaker G; Pagliuca A; Johnson P; Russell N; Cook G; Biol Blood Marrow Transplant; 2015 Mar; 21(3):483-8. PubMed ID: 25490180 [TBL] [Abstract][Full Text] [Related]
40. Haematopoietic stem cell transplantation for relapsed or refractory anaplastic large cell lymphoma: a study of children and adolescents in Japan. Fukano R; Mori T; Kobayashi R; Mitsui T; Fujita N; Iwasaki F; Suzumiya J; Chin M; Goto H; Takahashi Y; Hara J; Park YD; Inoue M; Koga Y; Inagaki J; Sakamaki H; Adachi S; Kawa K; Kato K; Suzuki R Br J Haematol; 2015 Feb; 168(4):557-63. PubMed ID: 25312752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]